A detailed history of Investment Advisory Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Investment Advisory Group, LLC holds 718 shares of VRTX stock, worth $341,107. This represents 0.12% of its overall portfolio holdings.

Number of Shares
718
Previous 711 0.98%
Holding current value
$341,107
Previous $333,000 -0.0%
% of portfolio
0.12%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$460.0 - $505.78 $3,220 - $3,540
7 Added 0.98%
718 $333,000
Q2 2024

Jul 31, 2024

SELL
$392.81 - $485.53 $392 - $485
-1 Reduced 0.14%
711 $333,000
Q1 2024

Apr 29, 2024

SELL
$407.69 - $446.08 $39,545 - $43,269
-97 Reduced 11.99%
712 $297,000
Q4 2023

Jan 30, 2024

BUY
$343.0 - $410.68 $277,487 - $332,240
809 New
809 $329,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Investment Advisory Group, LLC Portfolio

Follow Investment Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment Advisory Group, LLC with notifications on news.